USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Dec 31, 2021 (est) | Sep 30, 2021 | - | $-0.08 | $-0.06 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Dec 31, 2021 (est) | Sep 30, 2021 | - | $0.00 | $0.00 |
Second Sight Medical Products's next estimated earnings date (based on same quarter last year's date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 0 | $0.00 | $0.00 | $0.00 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-1.40 | $-1.40 | $-1.40 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 1 | $240.00K | $240.00K | $240.00K |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 17, 2021 | Jun 2021 | - | $-0.08 | - |
| Jun 30, 2021 | Mar 2021 | - | $-0.08 | - |
| Mar 31, 2021 | Dec 2020 | - | $-0.12 | - |
| Dec 31, 2020 | Sep 2020 | - | $-0.06 | - |
| Sep 30, 2020 | Jun 2020 | $-0.41 | $-0.07 | 83.10% |
| Jun 26, 2020 | Mar 2020 | $-0.41 | $-0.57 | -39.02% |
| Mar 19, 2020 | Dec 2019 | $-0.49 | $-0.47 | 4.08% |
| Nov 14, 2019 | Sep 2019 | $-0.48 | $-0.48 | - |
| Aug 6, 2019 | Jun 2019 | $-0.48 | $-0.48 | - |
| May 15, 2019 | Mar 2019 | $-0.48 | $-0.56 | -16.67% |
| Mar 13, 2019 | Dec 2018 | $-0.88 | $-0.88 | - |
| Nov 7, 2018 | Sep 2018 | $-1.12 | $-0.88 | 21.43% |
| Aug 7, 2018 | Jun 2018 | $-1.12 | $-0.88 | 21.43% |
| May 10, 2018 | Mar 2018 | $-0.14 | $-1.36 | -871.43% |
| Mar 7, 2018 | Dec 2017 | $-1.12 | $-1.28 | -14.29% |
| Nov 6, 2017 | Sep 2017 | $-0.13 | $-0.96 | -638.46% |
| Aug 1, 2017 | Jun 2017 | $-1.12 | $-0.86 | 22.90% |
| May 3, 2017 | Mar 2017 | $-1.12 | $-1.18 | -5.71% |
| Mar 9, 2017 | Dec 2016 | $-1.36 | $-1.92 | -41.18% |
| Nov 2, 2016 | Sep 2016 | $-0.16 | $-0.20 | -25.00% |
| Jul 28, 2016 | Jun 2016 | $-1.20 | $-1.36 | -13.33% |
| Apr 28, 2016 | Mar 2016 | $-1.28 | $-1.04 | 18.75% |
| Mar 3, 2016 | Dec 2015 | $-1.12 | $-1.04 | 7.14% |
| Oct 29, 2015 | Sep 2015 | $-0.14 | $-0.13 | 7.14% |
| Aug 4, 2015 | Jun 2015 | - | $-1.11 | - |
| May 13, 2015 | Mar 2015 | - | $-1.12 | - |
| Mar 11, 2015 | Dec 2014 | - | $-3.68 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $0.00 | $-0.82 | - |
| Mar 19, 2020 | Dec 2019 | $-2.22 | $-1.99 | - |
| Mar 13, 2019 | Dec 2018 | $-0.52 | $-4.00 | - |
| Mar 7, 2018 | Dec 2017 | $-0.55 | $-4.29 | - |
| Mar 9, 2017 | Dec 2016 | - | $-4.52 | - |
| Mar 3, 2016 | Dec 2015 | - | $-3.40 | - |
| Mar 11, 2015 | Dec 2014 | - | $-3.68 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 17, 2021 | Jun 2021 | - | $0.00 | - |
| Jun 30, 2021 | Mar 2021 | - | $0.00 | - |
| Mar 31, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Dec 31, 2020 | Sep 2020 | $240.00K | $0.00 | - |
| Sep 30, 2020 | Jun 2020 | $240.00K | $0.00 | - |
| Jun 26, 2020 | Mar 2020 | $240.00K | $497.00K | 2.07% |
| Mar 19, 2020 | Dec 2019 | $470.00K | $497.00K | 1.06% |
| Nov 14, 2019 | Sep 2019 | $940.00K | $472.00K | 0.50% |
| Aug 6, 2019 | Jun 2019 | $450.00K | $1.28M | 2.85% |
| May 15, 2019 | Mar 2019 | $1.66M | $1.13M | 0.68% |
| Mar 13, 2019 | Dec 2018 | $2.64M | $1.77M | 0.67% |
| Nov 7, 2018 | Sep 2018 | $2.48M | $2.25M | 0.91% |
| Aug 7, 2018 | Jun 2018 | $2.21M | $1.91M | 0.86% |
| May 10, 2018 | Mar 2018 | $976.00K | $976.00K | 1.00% |
| Mar 7, 2018 | Dec 2017 | $2.00M | $3.11M | 1.55% |
| Nov 6, 2017 | Sep 2017 | $1.61M | $1.61M | 1.00% |
| Aug 1, 2017 | Jun 2017 | - | $2.24M | - |
| May 3, 2017 | Mar 2017 | - | $1.01M | - |
| Mar 9, 2017 | Dec 2016 | - | $715.00K | - |
| Nov 2, 2016 | Sep 2016 | - | $1.18M | - |
| Jul 28, 2016 | Jun 2016 | - | $1.04M | - |
| Apr 28, 2016 | Mar 2016 | - | $1.05M | - |
| Mar 3, 2016 | Dec 2015 | - | $2.36M | - |
| Oct 29, 2015 | Sep 2015 | - | $2.23M | - |
| Aug 4, 2015 | Jun 2015 | - | $2.66M | - |
| May 13, 2015 | Mar 2015 | - | $1.70M | - |
| Mar 11, 2015 | Dec 2014 | - | $1.52M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 31, 2021 | Dec 2020 | $0.00 | $1.00K | - |
| Mar 19, 2020 | Dec 2019 | $3.35M | $3.38M | 0.87% |
| Mar 13, 2019 | Dec 2018 | $7.76M | $6.90M | -11.13% |
| Mar 7, 2018 | Dec 2017 | $6.80M | $7.96M | 17.12% |
| Mar 9, 2017 | Dec 2016 | - | $3.98M | - |
| Mar 3, 2016 | Dec 2015 | - | $8.95M | - |
| Mar 11, 2015 | Dec 2014 | - | $3.40M | - |
EYES's next estimated earnings date (based on same quarter last year's report date) is Dec 31, 2021 for the fiscal quarter ending Sep 30, 2021.
Second Sight Medical Products's previous earnings date was Aug 17, 2021 for its fiscal quarter ended Jun 30, 2021.
EYES's earnings per share (EPS) was $-0.08.
The EPS was higher than the previous fiscal quarter (Mar 2021) by 0.00%, and lower than the same period a year before (Jun 2020) by 15.44%.
Revenues were $0.00.
The company reported a net income of $-2.29M.Free cash flow for the quarter was $-4.18M , compared to $-778.00K last quarter and $-5.24M a year before.
EYES ended the quarter with $324.00K in total debt, a decrease of -87.37% compared to the previous quarter, and an increase of 205.66% compared to the same quarter a year before.
Second Sight Medical Products's previous annual earnings date was Mar 31, 2021 for its fiscal year ended Dec 31, 2020.
EYES's earnings per share (EPS) was $-0.82, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2019) by -59.01%.
Revenues were $1.00K.
The company reported a net income of $-14.88M.
Second Sight Medical Products reported a free cash flow of $-17.15M for its fiscal year, compared to $-28.12M a year ago.
The company ended the fiscal year with $2.20M in total debt, a decrease of -15.45% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
